Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)

Clinical trial NCT01616186 · WITHDRAWN

Trial details

NCT number: NCT01616186
Sponsor: Andrea Harzstark
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Metastatic Malignant Neoplasm

Start date: 2012-07-01
Primary completion: 2015-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.